X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-07 | XFOR | Taveras Arthur | Chief Scientific Officer | S - Sale | $0.56 | -76,920 | 388,026 | -17% | -$43,306 | ||||||
2024-03-11 | XFOR | Taveras Arthur | Chief Scientific Officer | S - Sale | $0.88 | -14,235 | 234,301 | -6% | -$12,552 | ||||||
2024-02-12 | XFOR | Taveras Arthur | Chief Scientific Officer | S - Sale | $1.01 | -787 | 248,536 | 0% | -$793 | ||||||
2023-11-01 | XFOR | Taveras Arthur | Chief Scientific Officer | S - Sale | $0.73 | -67,695 | 249,323 | -21% | -$49,417 | ||||||
2023-03-10 | XFOR | Taveras Arthur | Chief Scientific Officer | S - Sale | $0.84 | -16,806 | 86,373 | -16% | -$14,117 | ||||||
2023-02-13 | XFOR | Taveras Arthur | Chief Scientific Officer | S - Sale | $0.93 | -928 | 103,179 | -1% | -$863 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |